title: Mechanism of the stimulatory effect of native fucoidan, highly sulfated fucoidan and heparin on plasminogen activation by tissue plasminogen activator: the role of chloride.
abstract: Native Fucoidan and unfractionated heparin enhanced by 6-fold the in vitro activation of human glutamic plasminogen (Glu-Plg) by tissue plasminogen activator (t-PA) using 0.05M Tris buffer pH 7.4, while sulfated fucoidan inhibited the activation under these conditions. Double reciprocal plots of these interactions showed that sulfated fucoidan inhibited the activation in a noncompetitive manner while the enhancements by heparin or native fucoidan were due to an increase of Vmax without affecting Km. To determine whether the stimulatory effect of the individual cofactor was due to its interaction with Glu-Plg or with t-PA, experiments were performed at a fixed level of the cofactor and either varying in a serial fashion the concentration of Glu-Plg or of t-PA. The ratios of the initial rate of plasmin generation in the presence or absence of the cofactors were plotted against the inverse of the volume fraction of Glu-Plg or of t-PA. The results showed that heparin interacted with Glu-Plg while native fucoidan and sulfated fucoidan interacted with t-PA. Studies were also conducted on the effect of the two fucoidans and heparin on the activation of Glu-Plg by t-PA using 0.05M Tris buffer pH 7.4 containing 0.1 M NaCl. Under these conditions, sulfated fucoidan was most effective in enhancing the activation followed by native fucoidan and heparin respectively. The results of this study showed that in presence of the buffer containing 0.1 M NaCl, heparin was interacting with t-PA while the two fucoidans were interacting with both t-PA and Glu-Plg. A comparison of the double reciprocal plots of the rate of enhancement by the cofactors using 0.05M Tris buffer pH 7.4 containing 0.1M NaCl or in presence of buffer alone showed that the cofactors were more effective using 0.05M Tris buffer pH 7.4 alone and that addition of NaCl to the buffer slowed down the reactions by decreasing Vmax without affecting Km. Circular Dichroism (CD) studies of Glu-Plg in the far ultraviolet (UV) range showed that addition of NaCl destabilized the beta sheet structure which was reversed by addition of 6-aminohexanoic acid (6-AH) or one of the cofactors, while the near UV CD spectra of Glu-Plg in presence of 0.1 M NaCl was enhanced by the cofactors by increasing its ellipticity as reported earlier for 6-AH.
authors.affiliation: Department of Chemistry, Prairie View A&M University, Prairie View, Texas 77446, USA.
authors.forename: DeShawn
authors.initials: D
authors.lastname: Lang
authors.forename: Talya
authors.initials: T
authors.lastname: Williams
authors.forename: Altovise
authors.initials: A
authors.lastname: Phillips
authors.forename: V M
authors.initials: VM
authors.lastname: Doctor
mesh_terms: D002712:Chlorides / Q000502:physiology*; D006493:Heparin / Q000378:metabolism*; D010958:Plasminogen / Q000378:metabolism*; D011134:Polysaccharides / Q000378:metabolism*; D013431:Sulfates / Q000378:metabolism; D010959:Tissue Plasminogen Activator / Q000378:metabolism*
chemical_list: D002712:Chlorides; D011134:Polysaccharides; D013431:Sulfates; D010958:Plasminogen; D006493:Heparin; C007789:fucoidan; D010959:Tissue Plasminogen Activator
references.citation: Thromb Res. 1995 Aug 1;79(3):237-47
references.pmid: 8533120
references.citation: Thromb Res. 1994 Mar 1;73(5):301-11
references.pmid: 8016815
references.citation: J Biol Chem. 1978 Feb 10;253(3):727-32
references.pmid: 621200
references.citation: J Biol Chem. 1989 Feb 25;264(6):3618-23
references.pmid: 2914965
references.citation: Science. 1990 Apr 6;248(4951):69-73
references.pmid: 2108500
references.citation: Thromb Res. 1986 Jun 15;42(6):797-807
references.pmid: 3088755
references.citation: Proc Natl Acad Sci U S A. 1989 May;86(10):3619-23
references.pmid: 2726739
references.citation: Eur J Biochem. 1973 Nov 15;39(2):471-9
references.pmid: 4272770
references.citation: J Biol Chem. 1973 Sep 25;248(18):6490-505
references.pmid: 4738234
references.citation: J Cardiovasc Pharmacol. 1999 Oct;34(4):597-603
references.pmid: 10511137
references.citation: Blood Coagul Fibrinolysis. 2003 Apr;14(3):229-34
references.pmid: 12695744
references.citation: Biochemistry. 1986 Jul 15;25(14):4033-40
references.pmid: 2943315
references.citation: Biochemistry. 1995 Jul 25;34(29):9581-6
references.pmid: 7626628
references.citation: Proc Soc Exp Biol Med. 1957 Feb;94(2):404-9
references.pmid: 13408274
references.citation: Proc Natl Acad Sci U S A. 1987 Jun;84(12):4031-4
references.pmid: 3473492
references.citation: Eur J Drug Metab Pharmacokinet. 2003 Apr-Jun;28(2):161-6
references.pmid: 12877576
references.citation: Biochem Pharmacol. 1992 Apr 15;43(8):1853-8
references.pmid: 1533520
references.citation: J Biol Chem. 1990 Jan 5;265(1):241-7
references.pmid: 2294104
references.citation: Thromb Res. 1997 Jul 1;87(1):113-21
references.pmid: 9253806
references.citation: Thromb Res. 2000 Mar 1;97(5):349-58
references.pmid: 10709911
references.citation: J Biol Chem. 1962 Jan;237:75-80
references.pmid: 13868076
references.citation: Biochemistry. 1990 Jun 26;29(25):5906-11
references.pmid: 2143417
references.citation: Biochem J. 1988 Jan 1;249(1):77-81
references.pmid: 2449177
references.citation: Thromb Res. 1997 Sep 1;87(5):419-29
references.pmid: 9306616
references.citation: J Biol Chem. 1988 Feb 5;263(4):1698-708
references.pmid: 3338989